论文信息 - Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: A phase I trial of bortezomib plus bevacizumab - 字舞流文

Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: A phase I trial of bortezomib plus bevacizumab

K. Hess | C. Ng | E. Jackson | R. Kurzrock | F. Janku | A. Naing | D. Hong | J. Wheler | L. S. Angelo | G. Falchook | N. Tannir | H. Amin | A. Howard | K. Parkhurst | K. Lawhorn | Meixian Huang | D. Vishwamitra | Kristin L. Parkhurst